鼻至脑药物输送系统:一种新兴的化学疗法诱导认知障碍的方法
Shireesha Jannapu Reddy1, Srinivas Mutalik2, Gollapalle Lakshminarayanashastry Viswanatha3
1Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, 576104, Karnataka, India.
Pharmaceutical nanotechnology
|May 17, 2024
概括
化疗可以导致认知障碍,称为chemobrain. 纳米医学提供了一个有前途的解决方案,通过使用纳米颗粒和鼻内输送来改善药物进入大脑的途径,从而有可能减轻这些影响.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 化疗诱导的认知障碍 (化脑) 由于全球癌症负担日益增加,越来越令人担忧.
- 化疗虽然对癌症治疗至关重要,但可以导致严重的认知缺陷.
- 现有的化学脑治疗方法有限,需要新的治疗策略.
研究的目的:
- 探索纳米医学在缓解化疗引起的认知障碍方面的潜力.
- 审查创新的药物输送系统,特别是纳米粒子,以克服血脑屏障 (BBB).
- 评估内鼻途径向中枢神经系统 (CNS) 输送治疗药物的疗效.
主要方法:
- 对化学大脑在纳米医学中的应用进行当前研究的综述.
- 基于聚合物和脂质的纳米颗粒用于向药物输送的分析.
- 对中枢神经系统药物输送的鼻内注射策略的评估.
主要成果:
- 基于纳米颗粒的药物输送系统在克服BBB方面表现有前途.
- 从纳米配方中向释放药物可以提高治疗效果.
- 鼻内注射提供了一种潜在的途径来规避第一通代谢并改善中枢神经系统药物水平.
结论:
- 纳米配方,特别是通过鼻内输送,为管理化学大脑提供了一个有希望的方法.
- 对配方技术和化学大脑机制的进一步研究对于开发有效的治疗方法至关重要.
- 未来的方向包括新的药物组合和替代的输送途径,以提高纳米配方的有效性和安全性.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
268
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
268
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
231
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
231
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Drug Delivery: Parenteral Route
504
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
504
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
197
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
197


